We are live on
!
Find out more
BAMCO Inc Portfolio holdings
AUM
$66.6B
Turnover
22.96%
1-Year Est. Return
7.35%
This Fund
S&P 500
This Quarter
Est. Return
+14.11%
1 Year Est. Return
+7.35%
3 Year Est. Return
+62.2%
5 Year Est. Return
+84.27%
10 Year Est. Return
+776.55%
AUM
$37.7B
AUM Growth
+$2.78B
(+8%)
Cap. Flow
-$1.24B
Cap. Flow
% of AUM
-3.3%
Top 10 Holdings %
Top 10 Hldgs %
42.14%
Holding
347
New
18
Increased
90
Reduced
157
Closed
19
Avg Time Held
5.2
years
Top 10 Avg Time Held
7.8
years
Top 20 Avg Time Held
6.8
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vornado Realty Trust
VNO
|
+$61.5M |
| 2 |
Caesars Entertainment
CZR
|
+$55.6M |
| 3 |
GDS Holdings
GDS
|
+$48M |
| 4 |
Equinix
EQIX
|
+$41.7M |
| 5 |
Brookfield
BN
|
+$35.5M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Tesla
TSLA
|
+$134M |
| 2 |
West Pharmaceutical
WST
|
+$85.5M |
| 3 |
Gartner
IT
|
+$77.7M |
| 4 |
American Tower
AMT
|
+$77.6M |
| 5 |
Factset
FDS
|
+$74.1M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Consumer Discretionary | 26.11% |
| 2 | Financials | 22.57% |
| 3 | Technology | 21.25% |
| 4 | Healthcare | 9.69% |
| 5 | Real Estate | 8.72% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
276
Vaxcyte
PCVX
$10B
| $3.54M | 0.01% |
+31,000
| New | +$2.79M |
2024 Q3
0 quarters
|
|
277
Zoetis
ZTS
$32.8B
| $3.32M | 0.01% |
17,000
| – | – |
2019 Q4
19 quarters
|
|
278
ACV Auctions
ACVA
$1.78B
| $3.18M | 0.01% |
156,395
| – | – |
2021 Q1
14 quarters
|
|
279
Mitsubishi UFJ Financial
MUFG
$246B
| $3.01M | 0.01% |
295,681
-48,069
| -14% | -$507K |
2023 Q1
6 quarters
|
|
280
Insmed
INSM
$21B
| $2.96M | 0.01% |
+40,500
| New | +$2.99M |
2024 Q3
0 quarters
|
|
281
Progressive
PGR
$127B
| $2.94M | 0.01% |
11,600
| – | – |
2022 Q2
9 quarters
|
|
282
Certara
CERT
$1.43B
| $2.81M | 0.01% |
240,000
| – | – |
2020 Q4
15 quarters
|
|
283
HDFC Bank
HDB
$123B
| $2.8M | 0.01% |
89,396
-7,826
| -8% | -$241K |
2021 Q4
11 quarters
|
|
284
Ultragenyx Pharmaceutical
RARE
$1.43B
| $2.67M | 0.01% |
+48,000
| New | +$2.45M |
2024 Q3
0 quarters
|
|
285
Glaukos
GKOS
$9.72B
| $2.61M | 0.01% |
20,000
| – | – |
2024 Q2
1 quarter
|
|
286
Rivian
RIVN
$18B
| $2.54M | 0.01% |
226,546
-1,141,062
| -83% | -$16.4M |
2021 Q4
11 quarters
|
|
287
RadNet
RDNT
$5.41B
| $2.43M | 0.01% |
35,000
| – | – |
2024 Q1
2 quarters
|
|
288
Fiserv Inc
FISV
$25.3B
| $2.39M | 0.01% |
13,300
| – | – |
2022 Q3
8 quarters
|
|
289
Biohaven
BHVN
$1.63B
| $2.25M | 0.01% |
45,000
+10,000
| +29% | +$389K |
2024 Q2
1 quarter
|
|
290
BioNTech
BNTX
$22B
| $2.21M | 0.01% |
18,574
+8,724
| +89% | +$802K |
2020 Q4
15 quarters
|
|
291
Federal Realty Investment Trust
FRT
$9.24B
| $2.06M | 0.01% |
17,880
-5,974
| -25% | -$667K |
2024 Q2
1 quarter
|
|
292
Manchester United
MANU
$3.5B
| $1.8M | ﹤0.01% |
111,479
| – | – |
2013 Q2
45 quarters
|
|
293
Genmab
GMAB
$22.8B
| $1.76M | ﹤0.01% |
72,374
-14,779
| -17% | -$395K |
2020 Q4
15 quarters
|
|
294
T. Rowe Price
TROW
$21.5B
| $1.66M | ﹤0.01% |
15,260
-708
| -4% | -$77.7K |
2013 Q2
45 quarters
|
|
295
Surgery Partners
SGRY
$1.91B
| $1.29M | ﹤0.01% |
40,000
-45,000
| -53% | -$1.33M |
2023 Q4
3 quarters
|
|
296
Alexander's
ALX
$1.19B
| $1.21M | ﹤0.01% |
5,000
| – | – |
2013 Q2
45 quarters
|
|
297
Essent Group
ESNT
$5.82B
| $1.2M | ﹤0.01% |
18,653
-510,539
| -96% | -$31.2M |
2016 Q3
32 quarters
|
|
298
Kymera Therapeutics
KYMR
$8.71B
| $1.18M | ﹤0.01% |
+25,000
| New | +$1.1M |
2024 Q3
0 quarters
|
|
299
Blackrock
BLK
$176B
| $1.14M | ﹤0.01% |
1,200
-300
| -20% | -$260K |
2018 Q1
26 quarters
|
|
300
CarMax
KMX
$7.57B
| $1.09M | ﹤0.01% |
14,098
-2,669
| -16% | -$211K |
2013 Q2
45 quarters
|
|
Similar funds
BAMCO Inc's Q3 2024 Portfolio in Review
As of Q3 2024, BAMCO Inc held 347 positions worth $37.7B, up 8% from $34.9B the previous quarter. Its ten largest holdings account for 42% of the portfolio.
BAMCO Inc withdrew a net $1.24B in Q3 2024, closing 19 positions and reducing 157 holdings. Its most notable exit was Silk Road Medical, Inc. Common Stock, an estimated $34.6M position sold in full.
By sector, the portfolio is most concentrated in Consumer Discretionary at 26% of assets, up from 25% a quarter earlier, followed by Financials and Technology.
Against the trend, BAMCO Inc opened a new position in Vornado Realty Trust worth $75.3M.
- BAMCO Inc's largest Q3 2024 buy was Vornado Realty Trust: 1,912,359 shares worth $75.3M.
- BAMCO Inc added most to GDS Holdings in Q3 2024, an estimated $48M increase.
- BAMCO Inc's biggest Q3 2024 reduction was Tesla, cutting an estimated $134M.
- BAMCO Inc fully exited Silk Road Medical, Inc. Common Stock in Q3 2024, selling an estimated $34.6M.
- BAMCO Inc's ten largest holdings make up 42% of its $37.7B portfolio in Q3 2024.
- BAMCO Inc opened 18 new positions and closed 19 in Q3 2024.
- BAMCO Inc's portfolio value rose 8% quarter-over-quarter to $37.7B.
Based on BAMCO Inc's 13F filing for Q3 2024, filed 14 Nov 2024.